← Eichor
Study identifier: NCT07623148 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

GLP-1 RA Cessation and Gastric Ultrasound Findings

Condition: Residual Gastric Contents · Delayed Gastric Emptying  ·  Sponsor: Wonkwang University Hospital

PhaseN/A
Planned participants186
Who can joinAll sexes, 19 Years to 65 Years
Healthy volunteersNo

About this study

This prospective observational study will evaluate the association between the time interval since the last dose of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and residual gastric contents before elective surgery. Adult patients receiving GLP-1 RAs and scheduled for elective non-cardiac surgery under general anesthesia will undergo preoperative point-of-care gastric ultrasound. The study will assess whether longer GLP-1 RA cessation intervals are associated with lower ultrasound-estimated gastric volume and a lower frequency of high-risk gastric contents. Body mass index will also be evaluated as a potential modifier of this association.

This description comes directly from the study's public registry record.

Talk to the study team

Cheol Lee, M.D.,Ph.D  ·  +82-63-8591563  ·  ironyii70@gmail.com

Hyungjong Yu, M.D.

Always discuss trial participation with your own doctor first.

Locations (1)

Wonkwang University School of Medicine HospitalIksan, Jeonbuk-do, South KoreaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07623148